CELG.RT
Bristol-Myers Squibb Company Contingent Value Rights
CELG.RT
CELG.RT
22 hedge funds and large institutions have $57.2K invested in Bristol-Myers Squibb Company Contingent Value Rights in 2025 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 0 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
22
Holders Change
+2
Holders Change %
+10%
% of All Funds
0.3%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
2
Reduced
2
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
1 |
TSS
Two Sigma Securities
New York
|
$550 |
2 |
Citadel Advisors
Miami,
Florida
|
$885 |